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Abstract
Introduction:  Community-acquired  pneumonia  (CAP)  remains  a  common  and  serious  infection
with wide  variability  in  intra-hospital  mortality.
Methods:  We  performed  a  retrospective  analysis  of  adult  patients  admitted  with  CAP  in  main-
land Portugal  between  the  years  2000  and  2009.
Results:  The  intra-hospital  mortality  rate  was  20.4%  with  deaths  in  all  age  groups.  The  average
age of  deceased  patients  was  79.8  years,  significantly  higher  than  surviving  patients  with  71.3
years. Patients  aged  50  or  more  presented  a  relative  risk  of  death  4.4  times  the  risk  of  patients
under this  age  group.  Likewise,  in  patients  aged  65  or  more  the  risk  of  death  was  3.2  times
the risk  of  patients  <65  years.  Men  died  more  at  a  younger  age  than  women,  the  men  who  died
were, on  average,  4  years  younger  than  women,  78.1  vs  82.1  years  old.  Relative  risk  of  death
in men  was  17%  higher  than  women  after  adjustment  for  year  of  admission  and  age.
Conclusion:  CAP  remains  an  important  cause  of  hospital  mortality  in  all  age  groups.
© 2018  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
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ommunity-acquired  pneumonia  (CAP)  is  an  important  cause
f  morbidity  and  mortality  as  well  as  expenditure  of  healthnol.  2018.  https://doi.org/10.1016/j.pulmoe.2018.06.004
esources.  A  higher  incidence  of  this  disease  was  reported
n  men  and  older  patients.1
Elsevier España, S.L.U. This is an open access article under the CC
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Table  1  Evolution  of  intra-hospital  mortality  rate  between
2000 and  2009.
Year  Total  admissions  Deaths  (%)
2000  23,679  4046  (17.1%)
2001 22,442  4147  (18.5%)
2002 26,093  4930  (18.9%)
2003 27,978  5549  (19.8%)
2004 26,582  5366  (20.2%)
2005 31,302  6569  (21.0%)
2006 29,131  6320  (21.7%)
2007 33,726  7235  (21.5%)
2008 34,083  7652  (22.5%)
2009 39,011  8111  (20.8%)
2000--2004  126,774  24,038  (19.0%)
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Several  studies2--4 in  the  last  decade  showed  an  increase
n  hospital  admissions  for  CAP.  Portugal  was  no  exception.5
etween  2000  and  2009  CAP  was  responsible  for  3.7%  of  all
ospital  admissions  which  increased  to  7%  in  patients  ≥65
ears  of  age.5
CAP  is  the  leading  cause  of  death  by  infectious  disease
n  developed  countries,6 it  is  the  eighth  cause  of  death  in
he  United  States  (US)  in  2014.7 In  a  US  study  with  33,000
atients  conducted  in  1996,  CAP  intra-hospital  mortality  was
3.6%  increasing  to  36.5%  in  ICU  patients.8
In  European  countries,  mortality  due  to  CAP  varies.  In  a
012  review  with  more  than  30  studies  performed  over  9
uropean  countries,  Welte  et  al.1 concluded  that  variability
f  intra-hospital  mortality  in  CAP  was  significantly  related
o  several  factors.  This  led  to  mortality  rates  of  between
.0%  and  43%  depending  on  age  (≥65  years),  co-morbidities,
everity  (multilobar  pneumonia,  septic  shock,  ICU  admis-
ion),  immune  status,  antibiotic  sensitivity  and  response  to
reatment.
In  Portugal,  the  mortality  rate  in  adults  admitted  with
AP  between  1998  and  2000  was  17.3%  without  gender
redominance.9 Mortality  was  greater  in  older  patients,
anging  from  4.5%  in  those  younger  than  50  years,  19.4%  in
atients  ≥50  years  and  21.4%  in  those  older  than  ≥65  years.9
The  present  study  aims  to  describe  the  evolution  of  intra-
ospital  mortality  within  the  Portuguese  adult  population
dmitted  with  CAP  between  2000  and  2009  and  understand
ts  distribution  by  age  and  gender.
ethods
ata  was  gathered  through  the  Central  Administration  of  the
ational  Health  System  (NHS)  which  has  clinical  data  for  all
atients  admitted  to  Portuguese  NHS  hospitals.  This  covers
early  the  entire  resident  population  of  mainland  Portu-
al.  Medical  data,  including  diagnosis  and  procedures,  were
ncoded  from  the  discharge  summaries  by  trained  physi-
ians  using  the  International  Classification  of  Diseases,  9th
evision  --  Clinical  Modification  (ICD-9-CM).
In  this  study,  we  retrospectively  analyzed  the  hospital
dmissions  of  adults  with  a  primary  diagnosis  of  pneumonia
ICD-9-CM  480-486  and  487.0)  between  the  years  2000  and
009.  We  then  analyzed  all  inpatient  deaths  regardless  of
he  length  of  hospital  stay.  These  codes  excluded  tuberculo-
is  pneumonia,  obstructive  pneumonia  (e.g.  associated  with
ung  cancer),  patients  under  18  years  of  age  and  those  for
hom  pneumonia  was  not  the  main  diagnosis.  As  ICD-9-CM
oes  not  specify  whether  pneumonia  is  community  acquired,
e  excluded  patients  with  HIV  (ICD-9-CM  042-044  and/or
iagnosis-related  groups  488,  489  and  490),  individuals  who
ere  immunocompromised  by  anti-cancer  or  immunosup-
ressive  treatment  (external  cause  of  disease  code  E933.1)
nd  transplant  recipients  (V42).
Patient  anonymity  was  maintained  throughout  clinical
nalysis.  Comparison  of  the  mean  age  between  groups  was
erformed  using  the  Student’s  T  test  or  the  Mann--Whitney
est  when  the  assumptions  of  the  T  test  were  not  observed.Please  cite  this  article  in  press  as:  Teixeira-Lopes  F,  et  al.  Pulmo
he  risk  of  death  was  compared  between  age  groups,  gender
nd  year  of  admission  with  the  chi-squared  test.  The  relative
isk  of  inpatient  death  was  calculated  for  each  group  as  well
s  the  95%  confidence  interval.  To  measure  the  effect  of  each
b
y
a
2005--2009  167,253  35,887  (21.5%)
Total (2000--2009)  294,027  59,925  (20.4%)
ariable  (age  group,  gender  and  year  of  admission)  on  the
isk  of  death  adjusted  to  the  other  variables,  a  log-binomial
egression  was  used.  All  tests  used  had  a  significance  level
et  at  5%.  Data  analysis  was  performed  using  SPSS20  and
TATA  SE  11.
esults
nnual  intra-hospital  mortality  rates
etween  the  years  2000  and  2009,  294,027  adults  were
dmitted  to  hospital  with  a  main  diagnosis  of  CAP.  Of  those,
9,925  (20.4%)  died  during  their  hospital  admission.
Table  1  represents  the  inpatient  mortality  rate  per  year  of
dmission  between  2000--2004  and  2005--2009.  The  annual
ortality  rate  showed  a  steady  increase  between  the  period
000--2004  and  2005--2009  with  a  constant  rise  of  13.2%,
xcept  for  the  years  2007  and  2009.
ge  and  gender  characterization
he  patients  admitted  with  a  primary  diagnosis  of  CAP  had  a
ean  age  of  73.1  years  (standard  deviation  --  SD:  16.0).  The
eceased  patients  had  a  mean  age  of  79.8  years  (SD:  11.3)
nd  a  median  age  of  82  years.  This  was  significantly  higher
han  the  mean  age  of  the  surviving  patients  with  71.3  years
p  <  0.01).
The  inpatient  mortality  rate  for  male  patients  was  20.7%
hile  in  female  population  it  was  20.0%  (p  <  0.01).  Within
he  total  of  deceased  patients,  56.5%  were  male  with  a  mean
ge  of  78.1  years  and  43.5%  were  female  with  a  mean  age  of
2.1  years.  The  difference  between  the  mean  ages  in  both
roups  was  statistically  significant  (p  <  0.01).
There  were  deaths  in  all  age  groups,  however,  the  lowest
ortality  rate  was  observed  in  those  aged  29  years  with  a
ortality  rate  of  1.7%.
Table  2  represents  the  mortality  rate  of  admitted  patientsnol.  2018.  https://doi.org/10.1016/j.pulmoe.2018.06.004
y  gender  and  age  group  (<50,  ≥50,  <65,  ≥65,  <75,  ≥75
ears).
Regardless  of  gender,  the  risk  of  death  increased  with
ge.  The  relative  risk  of  death  for  patients  aged  50  or  more
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Table  2  Intra-hospital  mortality  by  gender  and  age  groups  (age  inferior  or  equal  to  and  greater  than  50,  65  and  75  years).
Male  Female  Total
Age  groups
(years)
Admitted
patients
Deaths  (%)  Admitted
patients
Deaths  (%)  Admitted
patients
Deaths  (%)
<50  19,167  1059  (5.5%)  11,137  456  (4.1%)  30,304  1515  (5.0%)
≥50 144,311  32,770  (22.7%)  119,411  25,640  (21.5%)  263,723  58,410  (22.1%)
<65 41,855  3527  (8.4%)  23,520  1388  (5.9%)  65,376  4915  (7.5%)
≥65 121,623 30,302  (24.9%)  107,028  24,708  (23.1%)  228,651  55,010  (24.1%)
<75 77,186  9686  (12.5%)  45,528  4259  (9.4%)  122,715  13,945  (11.4%)
≥75 86,292  24,143  (28.0%)  85,020  21,837  (25.7%)  171,312  45,980  (26.8%)
Total 163,478  33,829  (20.7%)  130,548  26,096  (20.0%)  294,027  59,925  (20.4%)
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was  4.4  times  (CI95%  4.2--4.7)  the  risk  for  those  under  this
age  group.  In  the  population  ≥65  years  the  relative  risk  of
death  was  3.2  times  (CI95%  3.1--3.3)  the  risk  of  the  <65  years
population  (p  <  0.01).
Table  3  represents  the  annual  evolution  of  mean  age  and
mortality  rate  in  patients  admitted  and  deceased  between
the  years  2000  and  2009.  Except  for  2009,  there  was  a con-
sistent  annual  increase  in  the  mean  age  as  well  as  mortality
rate.
Adjusted  mortality  rate  in  admitted  patients  (year,
age and  gender)
Table  4  represents  the  relative  risk  of  death  adjusted  for
year  of  admission,  age  and  gender.  The  relative  risk  of  death
varied  significantly  between  2001  and  2009  when  compared
to  2000.
Data  shows  a  steady  increase  in  mortality  rate  by  age
group,  with  a  small  variation  of  relative  risk  after  adjustingPlease  cite  this  article  in  press  as:  Teixeira-Lopes  F,  et  al.  Pulmo
for  year  of  admission  and  gender.
The  risk  of  death  was  higher  in  males  and  this  difference
was  even  higher  when  adjusted  for  year  of  admission  and
age.  Men  had  a  17%  higher  relative  risk  of  death  than  women.
b
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Table  3  Mean  ages  and  intra-hospital  mortality  rates  of  admitted
Year  Mean  age  (years)  
Admitted  patients  (N:  294,027)  Deceased
2000  70.1  78.1  
2001 71.3  78.3  
2002 71.6  79.0  
2003 72.1  79.3  
2004 73.3  79.7  
2005 73.8  80.0  
2006 73.8  80.0  
2007 74.2  80.5  
2008 75.0  80.8  
2009 73.6  80.7  
2000--2009 73.1  79.8  iscussion
rom  2000  to  2009  the  overall  intra-hospital  mortality  rate
or  patients  admitted  with  CAP  in  mainland  Portugal  was
0.4%.  This  is  within  the  range  observed  in  a  European
eview  published  in  20121 with  an  intra-hospital  mortality
ate  ranging  between  1%  and  43%.  Like  the  European  study
n  our  analysis  mortality  also  increased  with  age,  with  those
75  having  a  mortality  rate  of  26.8%,  more  than  twice  than
hose  <75,  which  had  11.4%  mortality  rate.  This  was  irre-
pective  of  year  of  admission  and  gender.  There  were  deaths
n  all  age  groups  with  a  highlight  5.0%  mortality  rate  in
atients  younger  than  50  years  old.  Over  the  studied  period
npatient  mortality  rate  showed  a  steady  increase,  with  two
xceptions:  2007  and  2009.  These  accompanied  changes  in
he  mean  age  of  hospitalized  and  deceased  patients.  The
verage  age  of  deceased  patients  was  significantly  higher,
9.8  years,  against  71.3  years  in  surviving  patients.
After  adjustment  for  age  and  gender,  the  increase  in
he  relative  risk  of  death  during  hospitalization  over  the
ears  maintained  statistical  significance,  with  an  11%  raisenol.  2018.  https://doi.org/10.1016/j.pulmoe.2018.06.004
etween  2000  and  2009.  Patients  aged  50  or  more  had  a
elative  risk  of  death  4.4  times  the  risk  of  patients  under
his  age  group.  Likewise,  in  patients  aged  65  or  more  the
isk  of  death  was  3.2  the  risk  of  patients  <65.  More  men
 and  deceased  patients  between  2000  and  2009.
Intra-hospital  mortality  rate  (%)
 patients  (N:  59,925)
17.1
18.5
18.9
19.8
20.2
21.0
21.7
21.5
22.5
20.8
20.4
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Table  4  Intra-hospital  mortality  adjusted  for  year  of  admission,  age  groups  and  gender.
Intra-hospital
mortality
Crude  relative
risk
95%  confidence
interval
Adjusted
relative  risk
95%  confidence
interval
Year
2000  17.09 Reference Reference
2001  18.48 1.08  1.04--1.12 1.04  1.00--1.08
2002 18.89  1.11  1.07--1.15  1.07  1.03--1.11
2003 19.83  1.16  1.12--1.20  1.10  1.06--1.14
2004 20.19  1.18  1.14--1.23  1.09  1.05--1.13
2005 20.99  1.23  1.19--1.27  1.12  1.08--1.16
2006 21.70  1.27  1.26--1.32  1.14  1.10--1.18
2007 21.45  1.26  1.21--1.30  1.13  1.09--1.16
2008 22.45  1.31  1.27--1.36  1.15  1.11--1.19
2009 20.79  1.22  1.18--1.26  1.11  1.07--1.14
p-value <0.001
Age  groups
18--29  3.47  Reference  Reference
30--49 5.43  1.56  1.36--1.79  1.54  1.34--1.76
50--64 9.69  2.79  2.45--3.18  2.74  2.41--3.12
65--74 15.75 4.54  3.99--5.16  4.47  3.94--5.08
75--84 23.31 6.71  5.91--7.62  6.65  5.85--7.55
≥85 32.03 9.23  8.12--10.48  9.28  8.17--10.54
p-value <0.001
Gender
Male 20.69  1.04  1.02--1.05  1.17  1.15--1.18
Female 19.99  Reference  Reference
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p-value  <0.001
ied  and  at  a  younger  age  than  women.  The  mean  age  of
eceased  men  was  78.1  years,  4  years  younger  than  the
ean  age  of  deceased  women  which  was  82.1  years.  Rel-
tive  risk  of  death  in  men  was  17%  higher  than  in  women
fter  adjustment  for  year  of  admission  and  age.
Our  study  has  several  limitations.  Primarily,  it  is  a  ret-
ospective  study  that  uses  an  administrative  database  with
oded  information  from  discharge  summaries.  However,  in
ortugal,  codification  is  done  only  by  medical  doctors  with
pecific  training.  The  process  is  regularly  internally  and
xternally  audited  which  contributes  to  guarantee  accuracy.
ue  to  the  lack  of  a  specific  CAP  code  in  ICD-9-CM,  we  only
nalyzed  adult  hospital  admissions  where  the  main  diagnosis
as  pneumonia.  Patients  with  a  main  diagnosis  of  respiratory
ailure  or  sepsis  associated  to  a  secondary  diagnosis  of  pneu-
onia  were  not  included.  The  latter  could  be  associated
ith  a  higher  mortality  rate10 but  also  with  nosocomial  pneu-
onia.  Still,  we  acknowledge  the  possibility  that  some  cases
f  hospital-acquired  pneumonia  could  have  been  included
n  our  study.  This  is  possible  due  to  coding  error  but  also
ecause  the  database  does  not  allow  for  discrimination  of
neumonia  after  recent  hospital  discharge,  hence  pneumo-
ia  that  is  not  strictly  community  acquired.  Similarly,  it  is  not
ossible  to  identify  patients  living  in  nursing  homes  or  using
ong-term  care  facilities,  hence  it  is  expected  that  cases
f  healthcare-associated  pneumonia  have  been  included,Please  cite  this  article  in  press  as:  Teixeira-Lopes  F,  et  al.  Pulmo
articularly  in  the  elderly.  However,  this  concept  and  its
nclusion  in  nosocomial  pneumonia  remain  the  source  of
ontroversy  for  some  authors  in  Europe.11 The  methodology
o
a
d
sed  made  it  impossible  to  exclude  all  rehospitalizations  of
he  same  patient  with  pneumonia  during  the  period  studied,
o  the  calculated  values  refer  to  hospital  admissions.
The  greater  accessibility  to  hospital  institutions  and  the
ear  of  dying  at  home,  both  for  patients  and  their  families,
ight  explain  the  inclusion  of  patients  with  end-of-life  pneu-
onia.  These  will  likely  have  a  higher  impact  in  the  older
ge  groups.
The  methodology  used  allowed  for  the  exclusion  of
atients  with  tuberculosis,  obstructive  pneumonia,  those
ith  HIV,  recipients  of  transplanted  organs,  the  immunosup-
ressed  and  those  under  treatment  for  cancer.
In  this  study,  the  length  of  hospitalization  was  not
ssessed,  which  could  have  contributed  to  a  greater  speci-
city  of  the  methodology.12 It  was  neither  possible  to  obtain
nformation  on  mortality  at  30  days  after  hospital  admis-
ion  or  to  identify  the  subset  of  patients  requiring  ICU
dmission.  Our  database  had  no  information  on  pneumonia
everity,  co-morbidities  or  immunization  status,  regarding
nfluenza  or  pneumococcal  disease.  Despite  these  limita-
ions,  the  methodology  used  has  been  considered  valid
nd  is  applied  in  multiple  studies  carried  out  in  different
ountries.3,5,9,13--15
This  study  has  the  advantage  of  analysing  a  period  of  10
ears,  minimizing  the  impact  of  years  that  deviate  from  nor-
ality,  such  as  2009,  when  the  A(H1N1)  influenza  pandemicnol.  2018.  https://doi.org/10.1016/j.pulmoe.2018.06.004
ccurred.  Regarding  the  year  2009,  there  were  more  CAP
dmissions5 and  this  could  be  related  to  the  influenza  pan-
emic,  but,  this  did  not  impact  on  intra-hospital  mortality,
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which  was  lower  in  2009  than  in  previous  years.  Mean  age  of
admission  could  be  a  contributing  factor  to  lower  mortality
since  it  was  lower  in  2009.  According  to  Portuguese  official
data  there  were  124  deaths  attributable  to  the  influenza
pandemic  through  serologic  testing  (1.17  deaths  per  100,000
inhabitants)  with  a  mean  age  of  47.6  years.16 In  summary,
during  the  influenza  pandemic  there  were  more  admissions
of  young  patients  with  CAP.
The  database  analysis  could  not  identify  factors  con-
tributing  to  the  annual  increase  in  intra-hospital  mortality
rates  even  after  adjusting  for  age,  gender  or  the  higher
risk  of  death  in  males.  Factors  such  as  smoking,  alcoholism,
severity  of  pneumonia,  clinical  management  of  the  disease
and,  above  all,  the  increasing  prevalence  of  comorbidities
in  the  Portuguese  population  may  be  associated  with  the
increase  in  mortality.
CAP  remains  an  important  cause  of  hospital  mortality
in  all  age  groups.  Further  studies  are  needed  to  better
understand  which  factors  are  associated  with  the  annual
increase  in  intra-hospital  mortality  rates.  However  our  study
fully  justifies  the  adoption  of  lifestyle-modifying  measures
as  well  as  greater  appreciation  of  anti-influenza  and  anti-
pneumococcal  vaccinations.17
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